Currently there is no open RFP for the Screening Platform.
Please refer to the GHIT Investment Opportunity schedule for the anticipated
future
RFP.
Apply for Funding
Screening Platform
Investment Process
Applicants
Contact Form Submission
Interested applicants must complete the Contact Form and submit this to submit by email to RFPResponse@ghitfund.org
Management Team
Eligibility Assessment
For all applications received for the Screening Platform, the GHIT Management Team will conduct eligibility assessments with a focus on partnerships, scope of disease, intervention, and development stage.
Applicants
Discussion with PDPs on project scope
All applications should be submitted as a collaboration between a Japanese organization and one of the following three PDPs: Medicines for Malaria Venture (MMV), Drugs for Neglected Diseases Initiative (DNDi), and the Global Alliance for TB Drug Development (GATB). The details of screening activities will be discussed with representatives from each partner.
Japanese organization-PDP-GHIT
Agreement
For approved projects, a three-way agreement (Japanese organization – PDP – GHIT) will be contracted, followed by the initiation of screening activities.
Management Team
Initiation of Monitoring and Evaluation
Once the agreement enters into effect, the GHIT Management Team will initiate the Monitoring and Evaluation process. The data and information regarding the project will be put into the system.
Management Team and Product Development Partners
Monitoring and Evaluation
To track the progress of each project, GHIT conducts progress updates twice a year. This enables us to keep track of the progress of investments and decide whether to continue, modify, or terminate the investment contingent upon milestone achievement. With this system, data pertaining to the progress of each project is gathered via an electronic system and the GHIT Management Team holds a conference with all product development partners based on the collected data prior to the meeting.